In this study, we investigated a cohort of small-for-gestational-age (SGA) newborns to evaluate whether growth hormone treatment during infancy serves as a protective factor against the onset of obesity in adolescence. Here, GH1 is linked to obesity due to melanocortin 4 receptor deficiency.